Financial Data and Key Metrics Changes - Comparable FFO for Q2 2025 was $0.56 per share, beating analyst consensus of $0.53 per share and remaining flat compared to Q2 2024 [27] - New York office occupancy increased to 86.7% from 84.4% in the previous quarter [28] - Net debt to EBITDA improved by 1.4 turns to 7.2 times from 8.6 times [24] Business Line Data and Key Metrics Changes - In Q2 2025, the company leased 2,700,000 square feet overall, with 2,200,000 square feet in Manhattan office space [12] - Average starting rents for Manhattan office leasing were $101 per square foot, with mark-to-markets of +11.8% GAAP and +8.7% cash [13] - PENN1 occupancy reached 90% after leasing 183,000 square feet at an average starting rent of $101 per square foot [13] Market Data and Key Metrics Changes - The Manhattan office market is described as a landlord's market with tight availability and no new supply expected through the end of the decade [11] - Replacement costs for Class A towers in Manhattan have risen to approximately $2,500 per square foot, with rents in the $200s now commonplace [10] - The overall demand for office space in Manhattan is strong, with significant expansion from clients [10] Company Strategy and Development Direction - The company remains focused on its New York-centric strategy, with plans to enhance the PENN District through various development projects [20] - Future developments include a residential project and modern retail offerings along Seventh Avenue [20][21] - The company aims to capitalize on rising rents and limited supply in the Manhattan market [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong leasing activity and a robust pipeline [28] - The company anticipates significant earnings growth by 2027 as leases at PENN1 and PENN2 come online [28] - Management highlighted the importance of disciplined capital allocation and the potential for significant rental growth in the coming years [82] Other Important Information - The company completed several financing transactions to bolster liquidity, including a $450 million financing with 1535 Broadway [23] - Cash balances increased to $1.36 billion, with total immediate liquidity of $2.9 billion [24] - The company is actively managing its debt maturities and refinancing opportunities [29] Q&A Session Summary Question: How much of the pending leasing activity is geared towards PENN2? - Approximately 50% of the 560,000 square feet in the leasing pipeline is at PENN2 [32] Question: Is the company looking to sell its assets in San Francisco? - The company is open to selling assets like The Mart and 555 California if the right price and timing arise, but there are no immediate plans [35] Question: What is the physical occupancy and rent coming online over the next year? - The company expects occupancy to increase to the low 90s over the next year, with significant income ramping up in 2027 [38] Question: What are the expectations for same-store NOI in the coming years? - Positive same-store NOI is expected as leasing activity increases, but specific percentages cannot be provided at this time [92] Question: What are the plans for the Forever 21 retail space? - The timing for backfilling the Forever 21 space is uncertain, but the company is optimistic about the retail corridor's potential [73]

Financial Data and Key Metrics Changes - For Q2 2025, the company recorded revenues of $14.7 billion, representing a 10% operational increase year-over-year [33] - Reported diluted earnings per share (EPS) was $0.51, while adjusted diluted EPS was $0.78, exceeding expectations due to strong top-line performance and effective cost management [34][37] - Adjusted gross margin for the quarter was approximately 76%, reflecting the product mix [35] Business Line Data and Key Metrics Changes - The Vyndaqel family achieved 21% year-over-year operational growth, contributing significantly to the company's performance [20] - The recently launched and acquired products generated $4.7 billion in revenue, growing approximately 15% operationally compared to last year [35] - The Paxlovid and Eliquis brands also showed strong contributions, while Ibrance experienced declines [34] Market Data and Key Metrics Changes - The international division saw strong performance, with 9% growth in emerging markets and 7% growth in Europe [84] - The oncology portfolio, particularly products like Lovren, contributed to a 6% growth driven by strong demand [84] - The company maintained leadership in the oral CGRP class with a 47% market share, despite pressures from net revenues due to the IRA Medicare Part D redesign [23] Company Strategy and Development Direction - The top strategic priority is improving R&D productivity, with a focus on key programs that address substantial patient needs [8] - The company is actively engaged in discussions with policymakers to navigate a complex geopolitical environment while maximizing business value [7] - The strategy includes leveraging technology such as AI and automation to drive productivity gains and streamline operations [7][45] Management's Comments on Operating Environment and Future Outlook - Management raised the adjusted diluted EPS guidance for the full year 2025, reflecting strong year-to-date performance [7] - The company is focused on maintaining a strong balance sheet and improving cash flow while managing external complexities [32] - Future guidance assumes favorable revenue impacts from foreign exchange rates and strong operational performance, despite potential volatility in COVID-related revenues [43][44] Other Important Information - The company is pursuing a licensing agreement with 3S Bio, which is expected to enhance its business development capacity [38] - The ongoing cost realignment program aims to achieve approximately $7.7 billion in savings by 2027, contributing to operating efficiencies [41] Q&A Session Summary Question: Guidance on potential price changes and Medicaid impact - Management is engaged in productive discussions regarding the MFN situation and tariffs, but cannot provide specific details at this time [50][51] Question: Insights on the CDC recommendations for vaccines - The company anticipates a strong vaccination season and has robust supply and distribution capabilities in place [56][58] Question: Capital allocation and leverage targets - The target leverage has been lowered to 2.7 times due to improved cash generation capabilities, with a focus on smaller deals for business development [61][64] Question: Development of PD-1/VEGF combinations - The company plans to start early development of combinations with ADCs without waiting for phase three readouts [69][70] Question: Efficiency in operating model and resource allocation - The company has implemented a new commercial model that has driven efficiencies and improved growth in key markets [86][88] Question: Competitive pressures and tax outlook - Management is aware of competitive pressures on certain products and is focused on maintaining a sustainable tax rate of approximately 13% going forward [100][101]

Financial Data and Key Metrics Changes - Revenue reached $241 million, representing reported revenue growth of 2% and organic revenue declines of 2% [7] - Adjusted gross margins held at 46% and adjusted EBITDA margin was 22%, both in line with expectations [8][29] - Non-GAAP adjusted earnings per share was $0.76, up 4% versus the prior year [29] - Operating cash flow for the quarter was $15 million compared to $41 million in the prior year, primarily driven by timing of tax payments and increased inventory purchases [29][30] Business Line Data and Key Metrics Changes - New product revenue grew by over 50% year over year, with a vitality index climbing to 21% of total sales [33] - Advanced surgery business experienced 17% growth year over year, driven by strong patient procedural growth rates [35] - Robotics and automation business unit revenue was up nearly 16% year over year, with a book to bill ratio of 1.05 [34] - Precision medicine business saw a 13% decline in sales year over year, but grew 10% sequentially [35] Market Data and Key Metrics Changes - Sales to medical device markets remained strong, driving sustained double-digit growth in advanced surgery [11] - Sales to industrial capital equipment saw declines year over year, but revenue has stabilized and bookings are rising at a double-digit pace [18] - Total China sales were up 15% year over year, despite challenges related to tariffs [80] Company Strategy and Development Direction - Long-term growth strategy focuses on markets with secular tailwinds such as precision and AI-driven robotics, minimally invasive surgery, and precision medicine [10] - The company aims to expand its portfolio into high-growth areas, increasing recurring consumables revenue to approximately 15% of sales [11] - The acquisition of Keon Technologies is expected to enhance the company's capabilities in RFID and AI-enhanced cloud-based software [30][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving $50 million of incremental new product revenue for 2025, mainly due to strong outlook for next-generation medical devices [12] - The company is optimistic about the growth in physical AI applications, expecting sales to double in 2026 versus 2025 [15] - Management acknowledged the impact of tariffs but indicated that mitigation strategies are in place, with a focus on regional manufacturing [37][40] Other Important Information - The company expects full-year 2025 GAAP revenue to be approximately $970 million to $985 million, representing overall revenue growth of 2% to 4% [41] - Adjusted EBITDA for the full year of 2025 is expected to be $225 million to $230 million, or approximately a 23% EBITDA margin [42] - The company has a strong balance sheet and credit facility, positioning it well for future acquisitions [47] Q&A Session Summary Question: Can you break down your revenue guidance? - The full year guidance indicates reported organic growth will likely be down 1% to up 1% [53] Question: What is the FX implied impact for benefit? - The FX impact is expected to carry forward from the second quarter [55] Question: What are the biggest drivers of organic growth in 2026? - Key drivers include advanced surgery product ramps, physical AI applications, and strong design wins [60][64] Question: Have we seen the low point for the year in industrial and precision medicine? - Management believes the industrial business has reached its bottom and will improve sequentially [72] Question: What is the status of the $35 million held up due to tariffs? - This amount is factored into guidance, and recovery is not assumed yet [79] Question: Can you elaborate on the warehouse robotics win? - The technology involves sensing and fast, safe reactions, essential for advanced warehouse automation [90]

Financial Data and Key Metrics Changes - The company achieved record revenue of just under $1,900,000,000 for Q2 2025, an increase of $327,000,000 or 20.9% from the prior year [21] - Gross profit for Q2 was $231,700,000, up $45,000,000 or 24.1% compared to the prior year, with gross margins improving to 12.3% from 11.9% [22] - Net income increased to $84,300,000 or $1.54 per fully diluted share, both up around 70% from the prior year [27] - Adjusted EBITDA was up over 30% to $154,800,000 compared to the prior year [27] Business Line Data and Key Metrics Changes - The Energy segment revenue increased by $263,300,000 or 27% from the prior year, driven by increased renewables activity [21] - The Utility segment revenue was up $72,200,000 or 11.6% from the prior year, driven by higher activity across all service lines [21] - Gross profit in the Utility segment was $97,500,000, up $33,500,000 or 52.3% compared to the prior year, with gross margins improving to 14.1% from 10.3% [23] - In the Energy segment, gross profit was $134,200,000 for the quarter, an increase of $11,500,000 or 9.4% from the prior year, but gross margins decreased to 10.8% from 12.6% [24] Market Data and Key Metrics Changes - The company is evaluating nearly $1,700,000,000 of work related to data centers, with optimism about winning a fair share [10] - There are between $20,000,000,000 and $30,000,000,000 of solar projects planned through 2028 on the company's sales radar [12] - The company expects a solid renewables bookings environment in the second half of the year and into 2026 [18] Company Strategy and Development Direction - The company aims to grow profitably through disciplined capital allocation and sees significant opportunities in power generation and utility infrastructure [7][10] - The strategy to improve utility margins is showing results, with a focus on attracting and retaining talent to meet growing demand [15][33] - The company is committed to disciplined bidding and project execution while managing risk to expand margins and increase cash flow [33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the demand backdrop, stating it is the best experienced by the company [31] - The outlook for gas operations is trending favorably, with more utilities opting for third-party service providers [13] - Management anticipates continued growth in the renewables sector despite some near-term uncertainties [18][19] Other Important Information - The company maintained strong liquidity of $690,000,000, including approximately $390,000,000 in cash [28] - Total backlog at the end of Q2 was just under $11,500,000,000, with MSA backlog up over $600,000,000 from Q1 [28][29] - The company updated its guidance for EPS to $4.4 to $4.6 per fully diluted share for the full year 2025 [29] Q&A Session Summary Question: Is the expectation for a back-end loaded order book still valid? - Management confirmed that they still predict a back-end loaded order book, with good bookings expected in Q3 and Q4 [36] Question: How much of the overall demand stems from MSA customers? - A significant portion of demand is driven by MSA work, particularly in gas and electric utilities [39] Question: What are the expectations for margins in the Utility segment? - The gross margin target for 2025 was increased to 10% to 12%, reflecting a structural shift due to various initiatives [44] Question: Can you quantify the closeout payments in the Utility segment? - Closeouts contributed about $6,000,000 of incremental gross profit during the quarter [51] Question: What is the outlook for pipeline projects? - Management remains optimistic about pipeline projects, expecting to see good bookings in the power generation side [56] Question: Is there potential for organic improvement in renewables gross margin? - While there is potential for improvement, margins are generally expected to remain stable [66]

Financial Data and Key Metrics Changes - Revenue for Q2 increased by 12% to $1.46 billion, while adjusted EBITDA rose by 17.2% to $318.6 million [13][7] - Total discharges for Q2 increased by 7.2%, with same-store discharges growing by 4.7% [7][13] - Net revenue per discharge increased by 4.2%, benefiting from a decrease in bad debt expense to 2% [13][14] - Adjusted free cash flow increased by 30.5% to approximately $186 million, bringing year-to-date adjusted free cash flow to approximately $408 million, a 31.7% increase from 2024 [15][16] Business Line Data and Key Metrics Changes - Neurological conditions and stroke discharges grew by 126.7% in Q2 [8] - The discharge community rate was 84.8%, with discharge to acute and SNF rates at 8.5% and 5.8% respectively, outperforming industry averages [8][11] - The company opened a new 60-bed hospital in Fort Myers, Florida, and added 26 beds to an existing hospital in Q2 [9] Market Data and Key Metrics Changes - The demand for inpatient rehabilitation services is significantly underserved, particularly as the U.S. population ages, with the Medicare beneficiary population projected to grow substantially [10] - The average age of Medicare beneficiaries is 77 years, with the population aged 65 and older growing at a CAGR of approximately 3% [10] Company Strategy and Development Direction - The company plans to open five additional hospitals and add 30 to 50 beds to existing hospitals by the end of the year [9] - The company is increasing its 2025 guidance for net operating revenue to between $5.88 billion and $5.98 billion, and adjusted EBITDA to between $1.22 billion and $1.25 billion [18] - The company continues to focus on treating complex medical conditions and developing best-in-class clinical protocols [11] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand for inpatient rehabilitation services remains considerably underserved, with a focus on treating patients with complex medical conditions [10] - The company is optimistic about future growth, citing favorable demographic trends and an increase in Medicare reimbursement rates [12][10] Other Important Information - The company repurchased approximately 232,000 shares for $24.7 million and announced an increase in its quarterly dividend to $0.19 per share [17] - The company has a favorable leverage and liquidity position, with net leverage at two times and approximately $100 million in unrestricted cash [16] Q&A Session Summary Question: What are the occupancy rates and comfort levels for single bedroom facilities? - Management indicated that occupancy in Q2 was 76.6%, up 210 basis points year-over-year, and that stabilization above 80% would prompt consideration for future bed expansions [22][24] Question: What is the company's stance on quality ratings and initiatives? - Management stated that any changes in quality initiatives did not make it into the final rule and expressed willingness to support quality measurements that are agreed upon by the industry [27][28] Question: How does the company share quality results with stakeholders? - Management shares quality metrics such as discharge community rates and patient satisfaction scores with joint ventures and referring physicians [32][34] Question: What is the story behind the increase in managed care pricing assumptions? - The increase is attributed to growth in the VA Community Care Network, which now comprises almost 18% of the managed care business and pays at Medicare CMG rates [38] Question: What are the expectations for EBITDA in the second half of the year? - Management expects to incur most preopening and ramp-up costs in the second half, with guidance reflecting potential increases in bad debt and other costs [42] Question: How is the company addressing benefits expense growth? - Management noted that benefits expense per FTE increased by 18%, driven by high dollar medical claims, and indicated that strategies are in place to manage these costs [100] Question: What is the outlook for outpatient visits and pricing? - Outpatient visits increased by 8% quarter-over-quarter, attributed to a good book of business in remaining facilities, despite a reduction in the overall footprint [124]

Financial Data and Key Metrics Changes - Consolidated reported sales growth was 3% or flat organic, with adjusted earnings per share at $1.93, exceeding original expectations [5][6] - Gross margins were pressured at 46.6%, down 170 basis points year over year, primarily due to foreign currency headwinds and inflation [19][20] - GAAP operating margin was 18.1%, with adjusted operating margin at 21.4%, down 200 basis points from the previous year [20] Business Line Data and Key Metrics Changes - Detection experienced mid single-digit organic growth driven by fixed and portable gas detection, growing 6% organically [8][10] - Fire Service organic sales declined mid single digits year over year, impacted by market dynamics surrounding NFPA standard changes [8][9] - Industrial PPE organic sales were down low single digits, with growth in fall protection offsetting declines in head protection and ballistic helmets [10][21] Market Data and Key Metrics Changes - In the Americas segment, sales increased 2% year over year, with double-digit growth in detection offset by declines in fire service and industrial PPE [21] - The International segment saw a 4% increase in sales on a reported basis, but a 4% decline on an organic basis due to lower volumes in fire service and detection [22] Company Strategy and Development Direction - The company continues to focus on its Accelerate strategy, emphasizing long-term value creation through organic growth, M&A, and cash returns to shareholders [10][13] - The acquisition of M and C Tech Group is expected to enhance fixed gas offerings and expand the total addressable market by $500 million [15][16] - The company is committed to investing in R&D to support new product development, with a focus on industrial safety technology [14][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the business and its ability to navigate macro uncertainties, maintaining a low single-digit full-year organic growth outlook [25][26] - The timing of NFPA approval and AFG funding release will significantly impact fire service execution in the second half [26][60] - Management expects interest expense to be approximately $29 million to $32 million, including the acquisition [27] Other Important Information - Free cash flow was $38 million, representing 60% of earnings, with quarterly operating cash flow increasing more than 25% from the previous year [22][23] - The company returned over $50 million to shareholders through stock repurchases and dividends, marking the 55th consecutive year of increased annual dividends [17][24] Q&A Session Summary Question: Can you break out and quantify the growth between fixed gas, non-connected portables, and connected portables in the quarter? - Management indicated strong performance in detection, particularly in fixed gas and MSA Plus connected portables, with most growth coming from MSA Plus [32][36] Question: How have customers responded to pricing actions and what was the magnitude of those actions? - Management noted that pricing actions were taken to mitigate inflation and tariff impacts, with customers generally accepting these increases [45][48] Question: What percentage of the current pipeline consists of customers committed to purchasing before the new standard? - Management refrained from disclosing specific percentages but indicated a solid pipeline and readiness for both current and future customer needs [50][52] Question: What is the timing and disbursement of AFG funding? - Management confirmed that AFG funding is approved and expected to begin releasing in August [58] Question: How does the company view fourth-quarter seasonality? - Management expects the fourth quarter to remain strong, consistent with historical performance [60] Question: What elements of timing are being monitored around the new NFPA standard? - Management highlighted key milestones in the government approval process, with expectations for approval between now and early 2026 [74][78] Question: Is M and C Tech Group accretive to margins? - Management stated that M and C's margins are similar to MSA's overall margins, thus neutral on margins but accretive to EPS [86]

Financial Data and Key Metrics Changes - Net sales for the second quarter were $1,340 million, down 1% on a constant currency basis [27] - Adjusted EBITDA was $293 million, up 3% on a constant currency basis [27] - Adjusted earnings per share increased to $0.89, up 7% as reported and 10% on a constant currency basis [28] - Adjusted tax rate improved to 24.4% from 25.5% in the same period last year [28] Business Line Data and Key Metrics Changes - Food segment net sales were $896 million, flat as favorable pricing offset softer volumes [30] - Protective segment net sales were $439 million, down 3% as reported and 4% in constant currency [33] - Food adjusted EBITDA was $210 million, up 3%, with a margin of 23.4%, up 50 basis points [32] - Protective adjusted EBITDA was $78 million, down 5%, with a margin of 17.8%, up 20 basis points from the first quarter [33] Market Data and Key Metrics Changes - The U.S. beef cycle saw a decline of 7% in slaughter rates, impacting the food segment [22] - EMEA region for food showed strength with volumes up low single digits [32] - North American market pressures accelerated in the second quarter, affecting food service and industrial processing [19] Company Strategy and Development Direction - The company is focused on transforming its Protective segment and improving customer engagement [12][14] - New product innovations include the Jiffy embossed paper mailer and hybrid auto vac solutions [15] - The company is optimizing its manufacturing footprint and has opened a new facility in Lakeland, Florida [16] Management's Comments on Operating Environment and Future Outlook - Management noted a stable second quarter despite global trade uncertainties and tariff impacts [10][11] - The company remains cautious about the second half of the year due to market uncertainties and lower growth expectations [17] - Management expressed confidence in the ongoing transformation and capital allocation discipline, with net debt below $4 billion for the first time since 2022 [25][26] Other Important Information - The company is maintaining its sales guidance range of $5.1 billion to $5.5 billion and adjusted EBITDA guidance of $1.075 billion to $1.175 billion [36] - Free cash flow guidance remains at $400 million, with capital expenditures expected to be lower than originally anticipated [38] Q&A Session All Questions and Answers Question: What does the volume impact for the second half look like for food? - Management expects a volume mix in the second half to be down three points in Q3 and Q4, primarily due to consumer spending shifts [46] Question: How should we think about near-term outlook for margins specific to food? - Management indicated that while there is a margin impact from volume loss, network optimization efforts are expected to balance out margins [55] Question: Can you talk about specific cost takeouts expected for the second half? - Management highlighted a focus on cost takeout initiatives, aiming for approximately $90 million in savings for the full year [60] Question: Are you seeing any slowdown in bidding and order activity? - Management reported no significant change in order patterns and remains optimistic about the performance of the industrial portfolio [71] Question: Why is the adjusted EBITDA range for 2025 so wide? - Management attributed the wide range to conservatism and low visibility regarding end markets, preferring to wait for more clarity in Q3 [78] Question: Can you describe your issue with procuring specialty resins? - Management clarified that there are no procurement issues but noted challenges related to tariffs impacting certain specialty resins [80]

Financial Data and Key Metrics Changes - Production increased by 10% quarter over quarter to 33,500 barrels of oil equivalent per day, within guidance [6] - Adjusted EBITDA grew by 9% to $35 million compared to 2024 [7] - Unrestricted cash increased to over $120 million while net debt decreased by about $15 million to under $230 million [7][11] - Total debt reduced from $393 million at year-end 2024 to $350 million at the end of 2025 [11] Business Line Data and Key Metrics Changes - Nine low-cost, low-risk workovers were performed, positively impacting production and revenue [6] - Five workovers in Mobile Bay contributed to increased production at this long-life asset [7] - Capital expenditures (CapEx) for 2025 totaled $19 million, with expectations for full-year CapEx between $34 million and $42 million [11][12] Market Data and Key Metrics Changes - SEC proved reserves reported at 123 million barrels of oil equivalent, slightly down from 127 million at year-end 2024 [15] - Approximately 44% of midyear 2025 proved reserves were liquids, with 34% crude oil and 10% NGLs, while 56% were natural gas [16] - The pre-tax PV-10 of proved reserves was flat at $1.2 billion compared to year-end 2024 [17] Company Strategy and Development Direction - The company focuses on operational excellence and maximizing production across its asset portfolio [6] - Emphasis on low-risk acquisitions of producing properties rather than high-risk drilling in the current commodity price environment [11][12] - Plans to continue enhancing shareholder value through dividends and strategic asset management [8][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate regulatory changes and market conditions [20] - Positive outlook for production increases in the second half of 2025, driven by workovers and new field ramp-ups [13][14] - Management highlighted the importance of maintaining liquidity and financial flexibility amid market volatility [10][11] Other Important Information - The company celebrated its 20th anniversary as a publicly listed entity on the NYSE [5] - Recent settlements with surety providers are expected to alleviate financial pressures and improve operational conditions [18][19] Q&A Session Summary Question: What actions may the administration take to incentivize production in the Gulf Of America? - Management mentioned potential lower royalties and the need to address the idle iron act, which they view as counterproductive [25][26] Question: What is driving the expected production ramp in Q3? - The COO indicated that low-cost workovers and ramping up acquired fields will contribute to increased production [30] Question: How do surety and bonding issues impact acquisition strategies and liquidity? - Management clarified that resolving these issues will positively affect M&A activity and liquidity, as previous demands were seen as collusive [34][40] Question: Can you provide details on the properties contributing to the positive reserve revisions? - Management noted that better performance from Cox assets and optimization projects in Mobile Bay contributed to the revisions [44][46]

Financial Data and Key Metrics Changes - Revenues for the second quarter were $188.5 million, reflecting a 3.6% increase year-over-year [20] - Same restaurant sales increased by 0.7%, driven by a 2.1% increase in average check, partially offset by a 1.4% decrease in transactions [21] - Restaurant level adjusted EBITDA was $44.5 million with a margin of 23.6%, a decrease of 90 basis points from the prior year [25] - Adjusted EBITDA for the quarter was $30.1 million, an increase of 0.7% from the previous year [26] - Cash from operations decreased by 31.1% year-over-year to $28.7 million year-to-date [28] Business Line Data and Key Metrics Changes - Non-comp restaurants contributed $6.1 million in revenue during the quarter, while same restaurant sales growth was flat on a two-year stack basis [20][21] - The company is on track to open 12 restaurants in 2025, with build costs reduced to an average of $5.2 million to $5.5 million per restaurant [12][29] Market Data and Key Metrics Changes - Transactions were down 1.4% for the quarter, but there was a sequential improvement of 170 basis points over Q1 [9] - The company is focusing on multichannel marketing in key markets like Phoenix and Dallas, which have shown sales lifts [10] Company Strategy and Development Direction - The company is focused on building awareness and driving transactions while maintaining high-quality food and guest experience [6] - Key initiatives include multichannel marketing, operational improvements, kiosk adoption, and evolving the Portillo's Perks loyalty program [10][12] - The company is refining its new market playbook, with a focus on sustained marketing investment in Texas [15] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges in Texas but remains confident in mid-teens revenue growth by 2026 [36] - The company is actively managing inflationary pressures through price increases and operational efficiencies [22][23] - Management expects total revenue growth for 2025 to be in the range of 5% to 7% [28] Other Important Information - Berkshire Partners redeemed $7.3 million in LLC units for Class A common stock, reducing their ownership to approximately 5.2% [18][19] - The company is nearly 90% hedged on beef prices, which is expected to mitigate inflationary impacts [62] Q&A Session Summary Question: Mix in the quarter and path to mid-teens revenue growth - Management explained that while kiosk usage increased items per transaction, there was a trade-down effect impacting the mix [38] - They remain confident in achieving mid-teens revenue growth by 2026 through foundational work in Texas [36] Question: Performance of new stores and marketing efforts - Management noted that some restaurants are entering their second year, and marketing efforts are ongoing to improve performance [43][45] Question: Labor and commodity inflation outlook - Management expects labor inflation to remain at 3% to 4% for the year, while commodity inflation is forecasted at 3% to 5%, primarily driven by beef [62][67] Question: Breakfast testing and limited menu impact - Breakfast testing is going well, appearing to be incremental without negatively affecting lunch or dinner sales [85] - The limited menu in Houston had some learnings, and management is adding back popular items [91] Question: Portillo's Perks loyalty program - The loyalty program has nearly 2 million members, and management sees potential for it to drive repeat frequency in expansion markets [99][103]

Financial Data and Key Metrics Changes - The company reported adjusted EBITDA of $203 million for the quarter, reflecting a 29% increase year-over-year with margins improving by 360 basis points [4][18] - Contract sales were down less than 1% for the quarter, an improvement compared to Q1, with first-time buyer sales up 6% year-over-year [6][15] - Delinquencies declined by 50 basis points sequentially and 110 basis points year-over-year, reaching the lowest levels in two years [15][29] Business Line Data and Key Metrics Changes - Owner sales declined by 4% due to lower VPGs, while owner tours remained flat [15] - Total company rental profit decreased by $7 million or 16% to $35 million, driven by increased unsold maintenance fees and marketing expenses [17] - Management exchange profit increased by 3% to $98 million, attributed to increased revenue in the vacation ownership segment [17] Market Data and Key Metrics Changes - The company achieved nearly 90% resort occupancy, with strong performance in Maui, Coastal Florida, and The Caribbean, while Las Vegas showed relative weakness [5] - First-time buyers represented a third of total contract sales in the quarter, up 200 basis points from a year ago [7] Company Strategy and Development Direction - The company is focused on modernization initiatives expected to deliver $150 million to $200 million in run rate benefits by the end of 2026, with half from revenue initiatives and half from cost savings [6][11] - The modernization program aims to enhance decision-making speed, optimize IT platforms, and drive growth in the leisure-focused business [7][12] - The company plans to restrict inventory spending to low-cost reacquired inventory and capital-efficient arrangements [21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of the business model and the continued prioritization of leisure travel by consumers [4][13] - Despite external uncertainties, the company expects high occupancy rates to continue and anticipates strong owner keys for the second half of the year [12][14] - The long-term financial model remains unchanged, with expectations for high single-digit to low double-digit EPS growth over time [14] Other Important Information - The company ended the quarter with $800 million in liquidity and a leverage ratio of 3.9 times [18] - Adjusted free cash flow is expected to be between $270 million and $330 million for the year, excluding one-time cash costs related to modernization initiatives [20] Q&A Session Summary Question: Contract sales trends in June and July - Management confirmed that July contract sales were up slightly from June, with June showing a 3% year-over-year increase [26][27] Question: Loan loss provision expectations - The loan loss provision guidance increased to 12.5%, which is about half a point higher than previous expectations, reflecting ongoing improvements in delinquencies [28][29] Question: Expanded owner benefits and EBITDA impact - The expanded owner benefit provides more options for owners but is not expected to significantly impact EBITDA growth [33][34] Question: Share buyback restrictions - Management indicated that there were blackout periods preventing share buybacks, but they plan to be opportunistic in the future [36][37] Question: Inventory efficiency and cost implications - The company aims to reduce inventory levels to one to two years on hand, with a slight increase in product costs expected over the next few years [45][46] Question: Loan loss provision increase despite improving delinquencies - Management explained that while delinquencies are improving, they are still higher than desired, prompting a conservative approach to the loan loss provision [53][54] Question: Sales performance in Maui - Maui showed strong year-over-year performance, with contract sales and occupancy rates improving, although some challenges remain [59]